Report cover image

United States Spinal Surgery Market Outlook to 2033 - Spinal Non-Fusion, Spinal Fusion, Vertebral Body Replacement Systems and Others

Publisher GlobalData
Published Sep 04, 2025
Length 79 Pages
SKU # GBDT20418756

Description

United States Spinal Surgery Market Outlook to 2033 - Spinal Non-Fusion, Spinal Fusion, Vertebral Body Replacement Systems and Others

Summary

GlobalData’s “United States Spinal Surgery Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Spinal Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Spinal Non-Fusion, Spinal Fusion, Vertebral Body Replacement Systems, Minimally Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices

The United States Spinal Surgery Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Spinal Surgery Market.
  • Global corporate-level profiles of key companies operating within the United States Spinal Surgery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

United States Spinal Surgery is segmented as follows -
  • Spinal Non-Fusion
  • Spinal Fusion
  • Vertebral Body Replacement Systems
  • Minimally Invasive Spinal Devices
  • Vertebral Compression Fracture Repair Devices
Reasons to Buy

The United States Spinal Surgery Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

79 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Spinal Surgery Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Spinal Surgery Market, United States
3.1 Spinal Surgery Market, United States, Revenue ($m), 2018-2033
3.1.1 Minimally Invasive Spinal Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Spinal Fusion Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Spinal Non-Fusion Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 Vertebral Body Replacement Systems Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.5 Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Spinal Surgery Market, United States, Volume (Units), 2018-2033
3.2.1 Minimally Invasive Spinal Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Spinal Fusion Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Spinal Non-Fusion Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 Vertebral Body Replacement Systems Market, United States, Volume (Units), by Segment, 2018-2033
3.2.5 Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Spinal Surgery Market, United States, Average Price ($), 2018-2033
3.4 Spinal Surgery Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Spinal Surgery Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Globus Medical Inc
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 DePuy Synthes Inc
4.4.1 Company Overview
4.5 Orthofix Medical Inc
4.5.1 Company Overview
5 Spinal Surgery Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Leap Distributors Acquires Leap Surgical and DUB Enterprises
6.2 Debt Offerings
6.2.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
7 Recent Developments
7.1 Corporate Communications
7.1.1 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.1.2 Feb 28, 2025: SMAIO Appoints Donald Blaskiewicz to US Scientific Advisory Board
7.1.3 Jan 13, 2025: SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales
7.1.4 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
7.2 Financial Announcements
7.2.1 Apr 18, 2025: Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
7.2.2 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel
7.2.3 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
7.2.4 Feb 04, 2025: Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
7.2.5 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
7.2.6 Jan 13, 2025: ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook
7.2.7 Jan 13, 2025: SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024)
7.2.8 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
7.2.9 Nov 08, 2024: SANUWAVE Posts Financial Results for Three Months Ended September 30, 2024
7.2.10 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
7.2.11 Nov 05, 2024: Globus Medical Reports Third Quarter 2024 Results
7.2.12 Nov 04, 2024: SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
7.2.13 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
7.2.14 Oct 30, 2024: MIMEDX Reports Q3 2024 Operating and Financial Results
7.2.15 Oct 15, 2024: Globus Medical Schedules Third Quarter Earnings Release and Conference Call
7.2.16 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
7.2.17 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
7.2.18 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
7.2.19 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.20 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
7.2.21 Jul 31, 2024: ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
7.2.22 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.23 Jul 10, 2024: ATEC to Report Second Quarter Financial Results on July 31, 2024
7.2.24 Jul 09, 2024: Orthofix to Report Second Quarter 2024 Financial Results
7.3 Government and Public Interest
7.3.1 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
7.3.2 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
7.3.3 Dec 09, 2024: ATEC to Present at the 2025 J.P. Morgan Healthcare Conference
7.3.4 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
7.3.5 Nov 04, 2024: ATEC to Participate in Upcoming Conferences
7.3.6 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
7.4 Legal And Regulatory
7.4.1 Jun 13, 2025: FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber Research
7.4.2 Jun 04, 2025: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
7.4.3 Feb 13, 2025: Zavation Receives 510(K) Clearance For Tiger 2 Pedicle Screw System
7.4.4 Dec 16, 2024: Treace Announces First Surgical Cases Utilizing the Speedplate Microquad Implant
7.4.5 Nov 11, 2024: Curasight Announces Brain Cancer as First Indication for Utreat : First Patient to Be Dosed Q2 2025
7.5 Other Significant Developments
7.5.1 Nov 26, 2024: CellRight Technologies Extends Multi-Year Distribution Agreement With Arthrex
7.6 Product News
7.6.1 May 12, 2025: Safe Group - Successful First Surgeries in Texas Following Purchase Contract
7.6.2 Mar 26, 2025: Viseon Announces Clinical Use of Hubble AV System
7.6.3 Mar 06, 2025: AcuityMD Presents New Outpatient Spinal Surgery Data at American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
7.6.4 Sep 24, 2024: Orthobond Supports Hospital for Special Surgery’s Presentation of New Landmark Study on Bacteria in Patients Undergoing Lumbar Spine Surgery at 2024 Nass Annual Meeting
7.6.5 Sep 18, 2024: ATEC to Spotlight Clinically Integrated Informatics at NASS 2024
7.6.6 Jul 24, 2024: Hinge Health Reduces Spinal Fusion Surgeries by 56%, New Study Shows
7.7 Strategy And Business Planning
7.7.1 Jan 08, 2025: Moonlake Initiates Three New Clinical Trials and Further Expands the Portfolio of Indications for the Nanobody Sonelokimab
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Minimally Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: Spinal Surgery Market, United States, Volume (Units), 2018-2033
Table 8: Minimally Invasive Spinal Devices Market, United States, Volume (Units), 2018-2033
Table 9: Spinal Fusion Market, United States, Volume (Units), 2018-2033
Table 10: Spinal Non-Fusion Market, United States, Volume (Units), 2018-2033
Table 11: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2018-2033
Table 12: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2018-2033
Table 13: Spinal Surgery Market, United States, Average Price ($), 2018-2033
Table 14: Spinal Surgery Market, United States, Company Share by Revenue ($m), 2024
Table 15: Spinal Surgery Market Pipeline Products
Table 16: Leap Distributors Acquires Leap Surgical and DUB Enterprises
Table 17: Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
Table 18: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Minimally Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: Spinal Surgery Market, United States, Volume (Units), 2018-2033
Figure 8: Minimally Invasive Spinal Devices Market, United States, Volume (Units), 2018-2033
Figure 9: Spinal Fusion Market, United States, Volume (Units), 2018-2033
Figure 10: Spinal Non-Fusion Market, United States, Volume (Units), 2018-2033
Figure 11: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2018-2033
Figure 12: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2018-2033
Figure 13: Spinal Surgery Market, United States, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us